Figure 2
From: Palliative radiotherapy in patients with a symptomatic pelvic mass of metastatic colorectal cancer
Symptom control rates according to the biologically equivalent dose (BED) and concurrent chemotherapy during RT (CCRT). (a) BED more than 40 Gy10 was a statistically significant prognostic factor (p = 0.0089) on univariate analysis in all cases. CCRT was a marginally significant factor (p = 0.0644) on univariate analysis in all cases. (b) In patients with pain, higher BED and CCRT was associated with improved outcome with statistical significance. (c) In patients with bleeding, only higher BED was statistically significant factor.